Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in ZYME — Zymeworks Inc.

CIK 886982 NEW YORK, NY
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$12,307,286
-$2,703,842 QoQ
Shares Held
470,822
-21.5% QoQ
Ownership
0.664%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 202 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. ZYME ranks #146 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in ZYME

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,307,286 470,822
2026-03-31 $15,011,128 599,486
2025-12-31 $11,064,049 420,207
2025-09-30 $7,575,406 443,525
2025-06-30 $5,382,154 428,857
2025-03-31 $2,382,559 200,047
2024-12-31 $3,659,414 249,960
2024-09-30 $3,156,036 251,477
2024-06-30 $1,477,344 173,601
2024-03-31 $2,846,143 270,546
2023-12-31 $2,084,452 200,621
2023-09-30 $1,068,740 168,571
2023-06-30 $1,649,176 190,877
2023-03-31 $2,965,825 328,078
2022-12-31 $982,948 125,057